China's healthcare reforms generate uncertainty for its domestic pharmaceutical market.
Outsourcing
Latest News
Advertisement
Taking Full Advantage of Service Providers
There are considerations companies may want to consider before seeking out a service provider.
Addressing PK/PD Study Design Early in Development
Strategizing a PK/PD study approach in early phase development facilitates a successful clinical progression.
Tech Transfer and Regulatory Compliance
Demand for efficient tech transfer, as well as compliant on-time delivery, is rising.
Advertisement
The census reveals the state of the population of India's health and the potential for growth in the healthcare market.
Industry announces plans for year ahead at annual JPMorgan Global Healthcare Conference.
The difficulties of doing business in China are offset by its adoption of more stringent GMP standards.
Contract organizations must have highly organized teams and plans to accommodate today's audits.
Government plans require investment, partnership, and industry collaboration.
Greater emphasis on focus and efficiency for companies as market demands value in 2012.
Some recent private-equity buyouts of CROs show both the upside and downside for investors.
A dearth of late-stage candidates could hurt the pharmaceutical services market in the future.
Readers react to the economic turmoil of the past year and look longingly forward to 2012.
Biosimilar manufacturers need better expression systems and analytical tools to compete.
Industrializing design, development, and manufacturing of therapeutic proteins.
With the rise in therapeutics comes more complex partnerships.
Single-use systems continue to gain traction among biomanufacturers, especially CMOs.
The author explains the current status of India, the challenges, and recommendations that may alleviate these challenges.
A Q&A with Rick Hancock, president of Althea Technologies. This article contains bonus online material.
The BioPlan Associates 8th annual survey identifies key outsourcing concerns of sponsor companies.
A survey provides insight into drug companies' plans for spending on outsourced services. This article contains bonus online material.
CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.
Knowing in advance what you need can make a huge difference in a sponsor company's success.
Developing a quality agreement template for single-use systems.
An interview with Oskar Gold, vice-president, key account management and corporate marketing, at Vetter.
The lower price of biosimilars will increase patient access to medicines and spur innovation.
The EU debt crisis portends of possible negative repercussions for the dose CMO industry.
China rises to the top as a destination for international outsourcing.
Advertisement
Advertisement